Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis
Primary Purpose
Cystic Fibrosis
Status
Terminated
Phase
Locations
Belgium
Study Type
Observational
Intervention
Rehabilitation
Sponsored by
About this trial
This is an observational trial for Cystic Fibrosis focused on measuring body composition, rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Cystic fibrosis
- stay at the rehabilitation center for at least 3 consecutive weeks
Exclusion Criteria:
- steroid use
- absence from the program for more than 2 consecutive days
Sites / Locations
- Zeepreventorium de Haan
Arms of the Study
Arm 1
Arm Type
Arm Label
rehabilitation
Arm Description
All included patients get an pre-intervention and a post intervention analysis
Outcomes
Primary Outcome Measures
body composition change
Dual energy X-ray absorptiometry measured Fat mass index (kg/m*2)
body composition change
Dual energy X-ray absorptiometry measured fat free mass (kg/m*2)
Body mass index change
calculated based on weight and height (kg/m*2) converted in standard deviations
Weight change
Scale weighed weight (kg) converted in standard deviations of normal population of normal populations
pulmonary function change
forced expiratory volume in 1 second (% of normal)
pulmonary function change
Forced Vital capacity (% of normal)
Secondary Outcome Measures
Physical activity
"SenseWear pro 3" armband measured physical activity
dietary intake
macronutrient intake measured based on 2 days/week weighed nutritional intake
Full Information
NCT ID
NCT04527796
First Posted
August 19, 2020
Last Updated
December 15, 2022
Sponsor
University Hospital, Ghent
1. Study Identification
Unique Protocol Identification Number
NCT04527796
Brief Title
Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis
Official Title
Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis (Children and Adults)
Study Type
Observational
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Terminated
Why Stopped
number included
Study Start Date
September 1, 2018 (Actual)
Primary Completion Date
May 1, 2020 (Actual)
Study Completion Date
July 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim is to evaluate the impact of a 3-week lasting residential rehabilitation program for patients with cystic fibrosis on their nutritional status measured as BMI and body composition and pulmonary function.
Detailed Description
Cystic fibrosis Patients following a residential rehabilitation program consisting of dietary adaptation, physical therapy for airway drainage and supervised inhalation therapy and physical activity for at least 3 weeks are asked to participate. Weight, height, body composition and pulmonary function will be measured at start and end of the program. Dietary intake during the program is calculated based on a 2 day weighed intake diary and physical activity will be measured with the "SenseWear pro 3" armband.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
body composition, rehabilitation
7. Study Design
Enrollment
39 (Actual)
8. Arms, Groups, and Interventions
Arm Title
rehabilitation
Arm Description
All included patients get an pre-intervention and a post intervention analysis
Intervention Type
Other
Intervention Name(s)
Rehabilitation
Intervention Description
During the rehabilitation program a multidisciplinary team, consisting of a pneumologist, dietician, psychologist, social worker and several physiotherapists, coach the cystic fibrosis patients.
The physiotherapists help with autogenic drainage and aerosol therapy (2-3 times/day) and supervise physical activity (5, 1-hour lasting, training sessions/week: swimming 2, Fitness training 2, 1 session of choice). The dietician calculates basal and theoretical energy needs . A carbohydrate-rich snack before exercise, to improve exercise tolerance and a carbohydrate-protein-rich snack afterwards to improve recuperation is provided.
Primary Outcome Measure Information:
Title
body composition change
Description
Dual energy X-ray absorptiometry measured Fat mass index (kg/m*2)
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Title
body composition change
Description
Dual energy X-ray absorptiometry measured fat free mass (kg/m*2)
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Title
Body mass index change
Description
calculated based on weight and height (kg/m*2) converted in standard deviations
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Title
Weight change
Description
Scale weighed weight (kg) converted in standard deviations of normal population of normal populations
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Title
pulmonary function change
Description
forced expiratory volume in 1 second (% of normal)
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Title
pulmonary function change
Description
Forced Vital capacity (% of normal)
Time Frame
day 0 and day 21 (start and end of the rehabilitation program)
Secondary Outcome Measure Information:
Title
Physical activity
Description
"SenseWear pro 3" armband measured physical activity
Time Frame
Week 1
Title
dietary intake
Description
macronutrient intake measured based on 2 days/week weighed nutritional intake
Time Frame
2 days/week for 3 consecutive weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cystic fibrosis
stay at the rehabilitation center for at least 3 consecutive weeks
Exclusion Criteria:
steroid use
absence from the program for more than 2 consecutive days
Study Population Description
Patients With Cystic Fibrosis
Sampling Method
Probability Sample
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephanie Van Biervliet, MD, PhD
Organizational Affiliation
Gent university hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zeepreventorium de Haan
City
De Haan
ZIP/Postal Code
8420
Country
Belgium
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Influence of a Residential Rehabilitation Program on Body Composition in Patients With Cystic Fibrosis
We'll reach out to this number within 24 hrs